Vasamed, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a VSMD research report →
Price Chart
About the company
Vasamed, Inc. specializes in the development, manufacturing, licensing, and distribution of a comprehensive suite of products, software solutions, and services focused on the assessment and management of circulatory health throughout the United States. Key among its offerings is the SensiLase PAD-IQ, a device designed to measure skin perfusion pressure, conduct pulse volume recordings, and calculate the Ankle-Brachial Index utilizing Doppler-derived pressure readings.
- CEO
- Paulita LaPlante
- IPO
- 1996
- Employees
- 5
- HQ
- Eden Prairie, MN, US
Get TickerSpark's AI analysis on VSMD
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $802
- P/E
- -0.00
- PEG
- 0.00
- P/S
- 0.00
- P/B
- 0.00
- EV/EBITDA
- -0.01
- Div Yield
- 0.00%
- Gross Margin
- -5.01%
- Op Margin
- 342.08%
- Net Margin
- -352.61%
- ROE
- 315.37%
- ROIC
- 742.82%
Latest fiscal year · YoY change
- Revenue
- $1.39M+29.7%
- Gross Profit
- $-69,388+78.2%
- Op Income
- $4.74M
- Net Income
- $-4,888,153+23.9%
- EPS
- $-1.31+29.2%
- OCF Growth
- -18.1%
- FCF Growth
- -21.5%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -1.01
- RSI (14)
- 0
- Avg Volume
- 60
No earnings-call transcripts are available for VSMD yet.
- Free Float
- 99.7%
- Shares Outstanding
- 8.02M
- Float Shares
- 8.00M
Our VSMD coverage
Recent articles, reports, and earnings notes.
No research on VSMD yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate VSMD report →Sintx Technologies (NASDAQ:SINT) versus Vasamed (OTCMKTS:VSMD) Critical Review
defenseworld.net · Apr 19
Head-To-Head Survey: Vasamed (OTCMKTS:VSMD) vs. Orthofix Medical (NASDAQ:OFIX)
defenseworld.net · Apr 17
Semler Scientific (NASDAQ:SMLR) & Vasamed (OTCMKTS:VSMD) Head-To-Head Survey
defenseworld.net · Dec 17
Head to Head Review: Hyperfine (NASDAQ:HYPR) vs. Vasamed (OTCMKTS:VSMD)
defenseworld.net · Nov 16
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.